Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Bortezomib 1.3 / Daratumumab 16 / Dexamethasone (20/20), Multiple Myeloma, Cycle 2-3

Protocol-ID: 818 V1.2 (Mini), BORT1.3/DRTM16/DEXA(20/20), MM, C2-3

Indication(s)

  • Multiple Myeloma; ICD-10 C90.-, C90.0-

Links

The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 15.04.2021